journal article·2025-07-14Open access

Substantiation of Prostate Cancer Risk Calculator Based on Physical Activity, Lifestyle Habits, and Underlying Health Conditions: A Longitudinal Nationwide Cohort Study

Jihwan Park

Applied Sciences· Volume 15· Issue 14

Abstract

Purpose: Despite increasing rates of prostate cancer among men, prostate cancer risk assessments continue to rely on invasive laboratory tests like prostate-specific antigen and Gleason score tests. This study aimed to develop a noninvasive, data-driven risk model for patients to evaluate themselves before deciding whether to visit a hospital. Materials and Methods: To train the model, data from the National Health Insurance Sharing Service cohort datasets, comprising 347,575 individuals, including 1928 with malignant neoplasms of the prostate, 5 with malignant neoplasms of the penis, 18 with malignant neoplasms of the testis, and 14 with malignant neoplasms of the epididymis, were used. The risk model harnessed easily accessible inputs, such as history of treatment for diseases including stroke, heart disease, and cancer; height; weight; exercise days per week; and duration of smoking. An additional 286,727 public datasets were obtained from the National Health Insurance Sharing Service, which included 434 (0.15%) prostate cancer incidences. Results: The risk calculator was built based on Cox proportional hazards regression, and I validated the model by calibration using predictions and observations. The concordance index was 0.573. Additional calibration of the risk calculator was performed to ensure confidence in accuracy verification. Ultimately, the actual proof showed a sensitivity of 60 (60.5) for identifying a high-risk population. Conclusions: The feasibility of the model to evaluate prostate cancer risk without invasive tests was demonstrated using a public dataset. As a tool for individuals to use before hospital visits, this model could improve public health and reduce social expenses for medical treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Prostate Cancer Diagnosis and Treatment · Global Cancer Incidence and Screening · Prostate Cancer Treatment and Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Liberal Arts, Dankook University, Cheonan-si 31116, Republic of Korea

Funding

Dankook university

References (41)

Show source-provided references
1. Cancer statistics, 202310.3322/caac.21763 ↗
2. National Cancer Information Center (2025, May 16). National Cancer Statistics 2021. Available online: https://www.cancer.go.kr/lay1/S1T639C641/contents.do.
3. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 202110.4143/crt.2024.253 ↗
4. Long-term functional outcomes after treatment for localized prostate cancer10.1056/NEJMoa1209978 ↗
5. Robotic assisted laparoscopic radical prostatectomy following transurethral resection of the prostate: Perioperative, oncologic and functional outcomes10.12954/PI.14046 ↗
6. Initial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing10.3346/jkms.2011.26.1.85 ↗
7. European randomized study of screening for prostate cancer risk calculator: External validation, variability, and clinical significance10.1016/j.urology.2016.11.004 ↗
8. Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low-vs high-grade prostate cancer10.1016/j.urology.2014.02.035 ↗
9. A prostate cancer risk calculator: Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men10.5489/cuaj.7380 ↗
10. Contemporary evaluation of the D’amico risk classification of prostate cancer10.1016/j.urology.2007.08.055 ↗
11. Use Of The Swop Calculator To Reduce Unnecessary Prostate Biopsies In Men With Elevated Psa: 052410.1016/j.ijsu.2012.06.513 ↗
12. Prostate cancer risk prediction based on complete prostate cancer family history10.1002/pros.22925 ↗
13. Personal sensing: Understanding mental health using ubiquitous sensors and machine learning10.1146/annurev-clinpsy-032816-044949 ↗
14. National Health Insurance Sharing Service (2025, May 16). National Health Insurance Sharing Service (NHISS) Bigdata Platform. Available online: https://nhiss.nhis.or.kr/.
15. Regression models and life-tables10.1111/j.2517-6161.1972.tb00899.x ↗
16. Fox, J., and Weisberg, S. (2002). Cox proportional-hazards regression for survival data. An R and S-PLUS Companion to Applied Regression, SAGE Publications, Inc.
17. Steck, H., Krishnapuram, B., Dehing-Oberije, C., Lambin, P., and Raykar, V.C. (2007). On ranking in survival analysis: Bounds on the concordance index. Advances In Neural Information Processing Systems, MIT Press.
18. ‘Prostate Cancer Risk Calculator’mobile applications (Apps): A systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS)10.1007/s00345-017-2150-1 ↗
19. Prediction of prostate cancer risk: The role of prostate volume and digital rectal examination in the ERSPC risk calculators10.1016/j.eururo.2011.11.012 ↗
20. Ambient air pollution and risk of prostate cancer: The multiethnic cohort study10.1158/1538-7445.AM2022-1437 ↗
21. Rotterdam prostate cancer risk calculator: Development and usability testing of the mobile phone app
22. Jeong, C.W., Lee, S., Jung, J.-W., Lee, B.K., Jeong, S.J., Hong, S.K., Byun, S.-S., and Lee, S.E. (2014). Mobile application-based Seoul National University Prostate Cancer Risk Calculator: Development, validation, and comparative analysis with two Western risk calculators in Korean men. PLoS ONE, 9.10.1371/journal.pone.0094441 ↗
23. Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study10.2196/16322 ↗
24. Mobile phone apps for the prediction of prostate cancer: External validation of the Coral and Rotterdam apps10.1016/j.ejso.2018.09.018 ↗
25. The CPC risk calculator: A new app to predict prostate-specific antigen recurrence during follow-up after radical prostatectomy10.1016/j.euf.2016.11.014 ↗
26. Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation10.1016/j.ejso.2021.04.033 ↗
27. Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators10.1200/JCO.2010.32.6371 ↗
28. Comparison of magnetic resonance imaging–based risk calculators to predict prostate cancer risk10.1001/jamanetworkopen.2024.1516 ↗
29. Lifestyle risk prediction model for prostate cancer in a Korean population10.4143/crt.2017.484 ↗
30. Ambient air exposures to arsenic and cadmium and overall and prostate cancer–specific survival among prostate cancer cases in Pennsylvania, 2004 to 201410.1002/cncr.34128 ↗
31. Association between environmental quality and prostate cancer stage at diagnosis10.1038/s41391-021-00370-z ↗
32. Ambient air pollution and prostate cancer risk in a population-based Canadian case-control study10.1097/EE9.0000000000000219 ↗
33. Bisphenol A and other environmental risk factors for prostate cancer in Hong Kong10.1016/j.envint.2017.06.012 ↗
34. Links between genetic and environmental factors and prostate cancer risk10.1002/(SICI)1097-0045(19990601)39:4<262::AID-PROS6>3.0.CO;2-P ↗
35. Non-dietary environmental risk factors in prostate cancer
36. Genetic and environmental factors in prostate cancer genesis: Identifying high-risk cohorts10.1159/000019910 ↗
37. Prostate cancer risk prediction models in Eastern Asian populations: Current status, racial difference, and future directions10.4103/aja.aja_55_19 ↗
38. Racial differences in the diagnosis and treatment of prostate cancer10.5213/inj.1632722.361 ↗
39. Racial differences in prostate cancer characteristics and cancer-specific mortality: An overview10.5534/wjmh.210070 ↗
40. Racial and ethnic differences in advanced-stage prostate cancer: The Prostate Cancer Outcomes Study10.1093/jnci/93.5.388 ↗
41. Explaining the race difference in prostate cancer stage at diagnosis10.1158/1055-9965.EPI-08-0203 ↗